In radionuclide therapy, a radioactive substance, or radionuclide, is attached to a molecule that targets cancer cells. This combination is introduced into the body, often through an injection. The molecule seeks out cancer cells, and the radionuclide emits radiation that kills these cells. The emitted radiation can be in the form of alpha particles, beta particles, or gamma rays, each having varying levels of penetration and effect on tissues.
